Results from a systematic programme of evaluating COVID-19 reinfection cases in the early phase of the pandemic, Singapore

Objectives: The objectives of this study were to describe the coronavirus disease caused by SARS-CoV-2 (COVID-19) reinfection evaluation algorithm used in the early phase of the pandemic in Singapore and analyze the clinical and laboratory characteristics of the cases evaluated. Methods: We performe...

Full description

Saved in:
Bibliographic Details
Main Authors: Tan, Glorijoy Shi En, Gao, Christine Qiuhan, Ow, Jievanda Shu Ying, Tan, Thuan Thong, Ooi, Say Tat, Lin, Cui, Lin, Raymond Tzer Pin, Lee, Vernon Jian Ming, Chan, Monica, Leo, Yee Sin, Vasoo, Shawn
Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
Format: Article
Language:English
Published: 2023
Subjects:
Online Access:https://hdl.handle.net/10356/169545
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-169545
record_format dspace
spelling sg-ntu-dr.10356-1695452023-07-30T15:37:52Z Results from a systematic programme of evaluating COVID-19 reinfection cases in the early phase of the pandemic, Singapore Tan, Glorijoy Shi En Gao, Christine Qiuhan Ow, Jievanda Shu Ying Tan, Thuan Thong Ooi, Say Tat Lin, Cui Lin, Raymond Tzer Pin Lee, Vernon Jian Ming Chan, Monica Leo, Yee Sin Vasoo, Shawn Lee Kong Chian School of Medicine (LKCMedicine) Tan Tock Seng Hospital National Centre for Infectious Diseases, Singapore Science::Medicine COVID-19 SARS-CoV-2 Objectives: The objectives of this study were to describe the coronavirus disease caused by SARS-CoV-2 (COVID-19) reinfection evaluation algorithm used in the early phase of the pandemic in Singapore and analyze the clinical and laboratory characteristics of the cases evaluated. Methods: We performed a retrospective case-control analysis including all COVID-19 cases evaluated for possible reinfection under the local COVID-19 reinfection evaluation programme between 1 June 2020-30 June 2021. Whole genome sequencing (WGS) was used as confirmatory testing. We compared all reinfection (“RI”) cases against those who were evaluated but eventually assessed not to be reinfection (“non-RI”). Results: There were 74 possible reinfection cases evaluated through the programme, of which 32 were subsequently classified as RI. There was strong statistical evidence that RI cases had a longer interval between 1st and 2nd episode (mean 297 days; 95%-confidence interval (CI) 267–327) compared to non-RI cases (mean 186 days; 95%-CI 144–228). The cycle threshold (Ct) value of initial polymerase chain rection (PCR) at 2nd episode was also found to be significantly lower in RI cases (mean 23; 95%-CI 20–26) compared to non-RI cases (mean 34; 95%-CI 32–36). There was no significant difference in the proportion of individuals who had fever, acute respiratory symptoms or asymptomatic in both groups. Delta and beta variants were most commonly identified from WGS and provide indication of re-infection as these were not ‘wild-type’ and were not circulating during the time period of the index infection. Conclusions: Using a combination of serologic, microbiologic and genomic criteria to evaluate possible reinfection cases is useful and can provide a framework for evaluation that may be modified for future similar situations. Published version 2023-07-24T02:53:50Z 2023-07-24T02:53:50Z 2023 Journal Article Tan, G. S. E., Gao, C. Q., Ow, J. S. Y., Tan, T. T., Ooi, S. T., Lin, C., Lin, R. T. P., Lee, V. J. M., Chan, M., Leo, Y. S. & Vasoo, S. (2023). Results from a systematic programme of evaluating COVID-19 reinfection cases in the early phase of the pandemic, Singapore. BMC Infectious Diseases, 23(1), 93-. https://dx.doi.org/10.1186/s12879-023-08056-8 1471-2334 https://hdl.handle.net/10356/169545 10.1186/s12879-023-08056-8 36788516 2-s2.0-85148087911 1 23 93 en BMC Infectious Diseases © The Author(s) 2023. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Science::Medicine
COVID-19
SARS-CoV-2
spellingShingle Science::Medicine
COVID-19
SARS-CoV-2
Tan, Glorijoy Shi En
Gao, Christine Qiuhan
Ow, Jievanda Shu Ying
Tan, Thuan Thong
Ooi, Say Tat
Lin, Cui
Lin, Raymond Tzer Pin
Lee, Vernon Jian Ming
Chan, Monica
Leo, Yee Sin
Vasoo, Shawn
Results from a systematic programme of evaluating COVID-19 reinfection cases in the early phase of the pandemic, Singapore
description Objectives: The objectives of this study were to describe the coronavirus disease caused by SARS-CoV-2 (COVID-19) reinfection evaluation algorithm used in the early phase of the pandemic in Singapore and analyze the clinical and laboratory characteristics of the cases evaluated. Methods: We performed a retrospective case-control analysis including all COVID-19 cases evaluated for possible reinfection under the local COVID-19 reinfection evaluation programme between 1 June 2020-30 June 2021. Whole genome sequencing (WGS) was used as confirmatory testing. We compared all reinfection (“RI”) cases against those who were evaluated but eventually assessed not to be reinfection (“non-RI”). Results: There were 74 possible reinfection cases evaluated through the programme, of which 32 were subsequently classified as RI. There was strong statistical evidence that RI cases had a longer interval between 1st and 2nd episode (mean 297 days; 95%-confidence interval (CI) 267–327) compared to non-RI cases (mean 186 days; 95%-CI 144–228). The cycle threshold (Ct) value of initial polymerase chain rection (PCR) at 2nd episode was also found to be significantly lower in RI cases (mean 23; 95%-CI 20–26) compared to non-RI cases (mean 34; 95%-CI 32–36). There was no significant difference in the proportion of individuals who had fever, acute respiratory symptoms or asymptomatic in both groups. Delta and beta variants were most commonly identified from WGS and provide indication of re-infection as these were not ‘wild-type’ and were not circulating during the time period of the index infection. Conclusions: Using a combination of serologic, microbiologic and genomic criteria to evaluate possible reinfection cases is useful and can provide a framework for evaluation that may be modified for future similar situations.
author2 Lee Kong Chian School of Medicine (LKCMedicine)
author_facet Lee Kong Chian School of Medicine (LKCMedicine)
Tan, Glorijoy Shi En
Gao, Christine Qiuhan
Ow, Jievanda Shu Ying
Tan, Thuan Thong
Ooi, Say Tat
Lin, Cui
Lin, Raymond Tzer Pin
Lee, Vernon Jian Ming
Chan, Monica
Leo, Yee Sin
Vasoo, Shawn
format Article
author Tan, Glorijoy Shi En
Gao, Christine Qiuhan
Ow, Jievanda Shu Ying
Tan, Thuan Thong
Ooi, Say Tat
Lin, Cui
Lin, Raymond Tzer Pin
Lee, Vernon Jian Ming
Chan, Monica
Leo, Yee Sin
Vasoo, Shawn
author_sort Tan, Glorijoy Shi En
title Results from a systematic programme of evaluating COVID-19 reinfection cases in the early phase of the pandemic, Singapore
title_short Results from a systematic programme of evaluating COVID-19 reinfection cases in the early phase of the pandemic, Singapore
title_full Results from a systematic programme of evaluating COVID-19 reinfection cases in the early phase of the pandemic, Singapore
title_fullStr Results from a systematic programme of evaluating COVID-19 reinfection cases in the early phase of the pandemic, Singapore
title_full_unstemmed Results from a systematic programme of evaluating COVID-19 reinfection cases in the early phase of the pandemic, Singapore
title_sort results from a systematic programme of evaluating covid-19 reinfection cases in the early phase of the pandemic, singapore
publishDate 2023
url https://hdl.handle.net/10356/169545
_version_ 1773551345123459072